Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T CellsMatthew J. Frigault, Carl H. June, Carmine Carpenito et al.|Cancer Immunology Research|2015Cited by 332
Th17 Cells in Cancer: The Ultimate Identity CrisisStefanie R. Bailey, Chrystal M. Paulos|Frontiers in Immunology|2014Cited by 327
Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansionJacob S. Bowers, Chrystal M. Paulos|JCI Insight|2017Cited by 69
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8 <sup>+</sup> T cellsConnor J. Dwyer, Chrystal M. Paulos|European Journal of Immunology|2020Cited by 64
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinomaSixue Liu, Roger S. Lo, Hannah M. Knochelmann et al.|Cell Reports Medicine|2021Cited by 57